Several biologic agents, such as monoclonal antibodies targeting IgE (omalizumab), IL-5 (mepolizumab), and IL-4/IL-13 (dupilumab), have shown efficacy in other allergic conditions like asthma and atopic dermatitis [12]. Here, IGHE is linked to asthma.